Article · Journal · 2016

A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of Malaria

ACS Infectious Diseases

Authors

36 authors across 15 institutions in 9 countries

Argonne National Laboratory
Biological and Environmental Research
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Medicines for Malaria Venture
National Institute of Allergy and Infectious Diseases
National Institutes of Health
U.S. Department of Energy
University of Chicago
Welch Foundation
Wellcome Trust

A work can sit in several, each with a score